Hepatitis C virus in hemophilia: Health‐related quality of life after successful treatment in the sixth Hemophilia in the Netherlands study

Abstract Introduction Persons with hemophilia and hepatitis C virus (HCV) infection have a lower health‐related quality of life (HRQoL) than those never HCV infected. However, it is unknown whether HRQoL after HCV eradication is comparable to individuals never HCV infected. We aimed to compare HRQoL between HCV‐cured and never chronically HCV‐infected persons with hemophilia. Methods All persons with hemophilia in the Netherlands were invited for a nationwide study conducted in 2018–2019. For the current analysis, participants born before 1992 with data on HRQoL and HCV status were included. H... Mehr ...

Verfasser: Cas J. Isfordink
Samantha C. Gouw
Erna C. vanBalen
Shermarke Hassan
Erik A. M. Beckers
Johanna G. van derBom
Michiel Coppens
Jeroen Eikenboom
Kathelijn Fischer
Louise Hooimeijer
Frank W. G. Leebeek
Frits R. Rosendaal
Saskia E. M. Schols
Cees Smit
Lize F. D. vanVulpen
Eveline P. Mauser‐Bunschoten
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Reihe/Periodikum: Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 8, Pp n/a-n/a (2021)
Verlag/Hrsg.: Elsevier
Schlagwörter: direct‐acting antivirals / hepatitis C virus / hemophilia A / hemophilia B / patient reported outcome measures / RAND‐36 / Diseases of the blood and blood-forming organs / RC633-647.5
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29172138
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1002/rth2.12616